MGRC Stock Overview
An investment holding company, provides genetics, genomics, immunotherapy, and biopharmaceutical services worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Malaysian Genomics Resource Centre Berhad Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | RM 0.27 |
| 52 Week High | RM 0.47 |
| 52 Week Low | RM 0.14 |
| Beta | 0.72 |
| 1 Month Change | 39.47% |
| 3 Month Change | -19.70% |
| 1 Year Change | -41.11% |
| 3 Year Change | -62.94% |
| 5 Year Change | -29.33% |
| Change since IPO | -71.81% |
Recent News & Updates
Recent updates
Is Now An Opportune Moment To Examine Malaysian Genomics Resource Centre Berhad (KLSE:MGRC)?
Mar 02
We Think Malaysian Genomics Resource Centre Berhad (KLSE:MGRC) Can Afford To Drive Business Growth
Feb 15Companies Like Malaysian Genomics Resource Centre Berhad (KLSE:MGRC) Are In A Position To Invest In Growth
Nov 02Shareholder Returns
| MGRC | MY Life Sciences | MY Market | |
|---|---|---|---|
| 7D | 0% | -2.4% | 0.4% |
| 1Y | -41.1% | 28.0% | -6.7% |
Return vs Industry: MGRC underperformed the MY Life Sciences industry which returned 28% over the past year.
Return vs Market: MGRC underperformed the MY Market which returned -6.7% over the past year.
Price Volatility
| MGRC volatility | |
|---|---|
| MGRC Average Weekly Movement | 19.5% |
| Life Sciences Industry Average Movement | 7.7% |
| Market Average Movement | 6.7% |
| 10% most volatile stocks in MY Market | 12.9% |
| 10% least volatile stocks in MY Market | 3.4% |
Stable Share Price: MGRC's share price has been volatile over the past 3 months compared to the MY market.
Volatility Over Time: MGRC's weekly volatility has increased from 10% to 19% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | n/a | Yien Leong | www.mgrc.com.my |
Malaysian Genomics Resource Centre Berhad, an investment holding company, provides genetics, genomics, immunotherapy, and biopharmaceutical services worldwide. It offers genome sequencing of various human, animal, plant, and microbes and other living organisms, such as whole genome and transcriptome sequencing, and metagenomics and metatranscriptomics services. The company also provides genome analysis services comprising bioinformatics services, including reads quality analysis, whole genome assembly, variation analysis of genomes, gene annotation, and exome and transcriptome analysis, as well as other analytical pipelines for processing ChIP-Seq data, annotating and analyzing microRNAs, and analyzing mutations; trait analysis services to screen multiple samples of previously identified genetic markers within plant and animal genomes; and trio sequencing services that provide a detailed view of an individual’s DNA.
Malaysian Genomics Resource Centre Berhad Fundamentals Summary
| MGRC fundamental statistics | |
|---|---|
| Market cap | RM 36.36m |
| Earnings (TTM) | -RM 4.16m |
| Revenue (TTM) | RM 5.79m |
6.3x
P/S Ratio-8.7x
P/E RatioIs MGRC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MGRC income statement (TTM) | |
|---|---|
| Revenue | RM 5.79m |
| Cost of Revenue | RM 2.32m |
| Gross Profit | RM 3.47m |
| Other Expenses | RM 7.63m |
| Earnings | -RM 4.16m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.03 |
| Gross Margin | 59.88% |
| Net Profit Margin | -71.94% |
| Debt/Equity Ratio | 0% |
How did MGRC perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/11 11:35 |
| End of Day Share Price | 2025/05/09 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Malaysian Genomics Resource Centre Berhad is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Seh Kong | CGS International |
| Ping-Khoon Choo | Kenanga Research |